Bimekizumab Efficacy and Safety in Patients With Psoriatic Arthritis Who Had Skin and Nail Psoriasis at Baseline: Up to 2-year Results From Two Phase 3 Studies. J of Skin [Internet]. 2024 Nov. 18 [cited 2025 May 18];8(6):s435. Available from: https://skin.dermsquared.com/skin/article/view/3112